Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Combinational use of drugs has been a common strategy in cancer treatment because of synergistic advantages in reducing dose and toxicity, minimizing or delaying drug resistance. To improve the efficacy of chemotherapy, various potential combinations have been investigated. Ruthenium complex is cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ke, Rong, Yi, Chen, Dan, Zhao, Zizhuo, Bo, Huaben, Qiao, Aimin, Hao, Xiaojuan, Wang, Jinquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041628/
https://www.ncbi.nlm.nih.gov/pubmed/32133289
http://dx.doi.org/10.3389/fonc.2020.00141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041628/
https://www.ncbi.nlm.nih.gov/pubmed/32133289
http://dx.doi.org/10.3389/fonc.2020.00141

Ejemplares similares